Steve Kelsey
Net worth: 43 M $ as of 2026-04-29
Net worth: 43 M $ as of 2026-04-29
Stephen M.
Kelsey is currently Independent Director at Circle Pharma, Inc. since 2022, Independent Director at Jiya Acquisition Corp.
since 2020, and President-Research & Development at Revolution Medicines, Inc. since 2017.
Formerly, Dr. Kelsey was Director-Clinical Affairs at Pharmacia Corp.
in 2002, Vice President-Clinical Hematology & Oncology at Genentech, Inc. in 2009, Chief Medical Officer & Executive Vice President at Geron Corp.
from 2009 to 2013, Senior Vice President-New Projects at Medivation LLC (California) from 2013 to 2014, and President at Onkaido Therapeutics LLC from 2014 to 2017.
Education includes undergraduate, graduate, and doctorate degrees from the University of Birmingham.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-16 | 295,398 ( 0.14% ) | 43 M $ | 2026-04-29 |
| Companies | Position | Start |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Chief Tech/Sci/R&D Officer | 2017-02-28 |
| JIYA ACQUISITION CORP. | Director/Board Member | 2020-11-17 |
Circle Pharma, Inc.
Circle Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Director/Board Member | 2022-12-14 |
| Companies | Position | End |
|---|---|---|
Onkaido Therapeutics LLC
Onkaido Therapeutics LLC Pharmaceuticals: MajorHealth Technology Offers advancement of oncology products for previously undruggable targets and as a superior alternative to existing drug modalities | President | 2017-02-28 |
| MEDIVATION INC | Corporate Officer/Principal | 2014-05-31 |
Genentech, Inc.
Genentech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 2009-03-31 |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Chief Tech/Sci/R&D Officer | 2002-05-31 |
| GERON CORPORATION | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
University of Birmingham
University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Circle Pharma, Inc.
Circle Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Onkaido Therapeutics LLC
Onkaido Therapeutics LLC Pharmaceuticals: MajorHealth Technology Offers advancement of oncology products for previously undruggable targets and as a superior alternative to existing drug modalities | Health Technology |
Revolution Medicines, Inc.
Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
Jiya Acquisition Corp.
Jiya Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Select your edition
All financial news and data tailored to specific country editions